[Sinus rhythm and standard deviation in cardiac cycles. Influence of myocardial status and beta-blocker treatment]

Arch Mal Coeur Vaiss. 1989 Dec;82(12):1993-2000.
[Article in French]

Abstract

The efficacy of beta-blockers in preventing sudden death after myocardial infarction would seem to be greater in patients with cardiac failure and proportional to the reduction in heart rate induced by these drugs. In addition, a reduction in heart rate variability measured by the standard deviation from the average cardiac cycle over 24 hours has been reported to be an independent bad prognostic factor after myocardial infarction. This study compares the heart rates and the standard deviations from the mean cardiac cycle over 24 hours in 41 patients divided into 3 groups of comparable age (group I: normal subjects, n = 15; group II: hypertrophic cardiomyopathy without cardiac failure, n = 13; group III: cardiac failure, n = 13) before and after administration of acebutolol (10 mg/kg). The average 24 hour heart rates, the maximum 8-hour diurnal and minimum average 4-hour nocturnal heart rates, day-night ratio and standard deviations from the average 24 hour heart rate and at the hours of maximum and minimum average heart rates were measured by Holter monitoring with an ATREC II system. The 24 hour heart rates were slower in groups II (-18.1 p. 100) and III (-19.1 p. 100) than in group I (-9.5 p. 100), p less than 0.01, the basal heart rates being comparable and the heart rates after acebutolol being significantly lower in groups II and III. The degree of change was comparable during the diurnal and nocturnal periods.(ABSTRACT TRUNCATED AT 250 WORDS)

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • English Abstract

MeSH terms

  • Acebutolol / pharmacology*
  • Cardiomyopathy, Hypertrophic / drug therapy*
  • Circadian Rhythm
  • Electrocardiography, Ambulatory
  • Female
  • Heart Failure / drug therapy*
  • Heart Rate / drug effects*
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Statistics as Topic*

Substances

  • Acebutolol